gallic acid has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, JR; Keiser, H; Ohman, KP; Yun, JC | 1 |
Hunt, JA; Keen, M | 1 |
Angerio, AD; Kot, PA; Ramwell, PW; Santoian, EC; Schneidkraut, MJ | 1 |
Aljada, A; Dandona, P; Khurana, U; Love, J; Mousa, S; Thusu, K | 1 |
Bauer, J; Parekh, N | 1 |
5 other study(ies) available for gallic acid and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Bucladesine; Calcium; Calcium Channel Blockers; Colforsin; Cyclic AMP; Cytosol; Egtazic Acid; Female; Gallic Acid; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Thromboxane A2; Verapamil | 1991 |
Mechanism of thromboxane receptor activation of phospholipase A2 in endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Calcium; Calcium Channel Blockers; Cattle; Cell Line; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Gallic Acid; Kinetics; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes | 1991 |
Role of calcium in U 46619 and PGF2 alpha pulmonary vasoconstriction in rat lungs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Calmodulin; Dinoprost; Gallic Acid; In Vitro Techniques; Lung; Male; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rats; Rats, Inbred Strains; Trifluoperazine; Vasoconstriction | 1989 |
Calcium, calmodulin and protein kinase C dependence of platelet shape change.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Binding Sites; Blood Platelets; Calcium; Calcium Channel Blockers; Calmodulin; Cell Size; Chelating Agents; Edetic Acid; Gallic Acid; Humans; Intracellular Fluid; Mesylates; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 1996 |
Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Calcium Channel Blockers; Enzyme Inhibitors; Female; Gallic Acid; Indoles; Nifedipine; Norepinephrine; Pyridines; Rats; Rats, Wistar; Renal Circulation; Signal Transduction; Staurosporine; Vasoconstrictor Agents | 2003 |